Elevated methemoglobin levels in patients treated with hydroxocobalamin: a case series and in-vitro analysis.

MLA

Kiernan, Emily Anne, et al. “Elevated Methemoglobin Levels in Patients Treated with Hydroxocobalamin: A Case Series and in-Vitro Analysis.” Clinical Toxicology (Philadelphia, Pa.), vol. 60, no. 9, Sept. 2022, pp. 1012–18. EBSCOhost, https://doi.org/10.1080/15563650.2022.2072315.

APA

Kiernan, E. A., Carpenter, J. E., Dunkley, C. A., Moran, T. P., Rothstein, L. S., Silver, E., Salehi, M., Koch, D. D., Morgan, B. W., & Murray, B. P. (2022). Elevated methemoglobin levels in patients treated with hydroxocobalamin: a case series and in-vitro analysis. Clinical Toxicology (Philadelphia, Pa.), 60(9), 1012–1018. https://doi.org/10.1080/15563650.2022.2072315

Chicago

Kiernan, Emily Anne, Joseph E Carpenter, Camille A Dunkley, Tim P Moran, Lindsay Schaack Rothstein, Elizabeth Silver, Maryam Salehi, David D Koch, Brent W Morgan, and Brian Patrick Murray. 2022. “Elevated Methemoglobin Levels in Patients Treated with Hydroxocobalamin: A Case Series and in-Vitro Analysis.” Clinical Toxicology (Philadelphia, Pa.) 60 (9): 1012–18. doi:10.1080/15563650.2022.2072315.